We use Google Analytics to see which pages are read and how the site is used, so we know what to improve. This only runs if you accept. See our privacy notice for details.

Dáil

Written answer

Medicinal Products

Summary

The Minister referred concerns about delisted medicines and their financial impact on low-income patients to the HSE, which is responsible for reimbursement decisions.

3219. Deputy Richard Boyd Barrett asked the Minister for Health the reason certain items (details supplied) have been delisted from the drug payment scheme; if she will consider the financial impact this causes for those who are on low incomes but are ineligible for a full medical card, and often have to pay the full €80 DPS limit; and if she will make a statement on the matter. [55259/26]

Comment on this

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Comment on this